Angel Yeast unveils patented probiotic touted for being “effective against diarrhea”
03 Sep 2021 --- China-based Angel Yeast Co. has developed a new strain of yeast probiotic, Saccharomyces boulardii Bld-3 (S. boulardii Bld-3). The patented yeast probiotic is designed to strengthen healthy digestive and immune systems in children and adults.
“Saccharomyces boulardii (S. boulardii) is a probiotic that has been considered a crucial nutritional intervention in treating diarrhea,” says Dr. Zhang Yan, CTO of Angel Nutritech, a company established in 1992 by Angel Yeast.
“The new strain of yeast probiotic developed by Angel Nutrition & Health Technical Center, S. boulardii Bld-3, is another addition to the S. boulardii family that has been proven effective in speeding up recovery from acute diarrhea and is beneficial to intestinal health in the long term.”
COVID-19 has prompted an increasing number of consumers to pay attention to their health and an increased focus on preventive measures and healthcare products that prevent diseases and support their immune systems.
On Google Trends, the search queries “gut health” and “probiotic” have seen several spikes during the COVID-19 pandemic.
For gastrointestinal healthcare, keyword searches related to probiotics also climbed to a record high this year, signaling increased recognition of its robust ability to restore and maintain a healthy digestive system for humans.
Just last month, probiotics and pro-inflammatory cytokines were touted to have the potential to help reduce inflammation and modulate an overactive immune system, according to A&B Ingredients.
Meanwhile, probiotic-rich products are appealing to a broader range of consumers while providing health and immune benefits.
In June, Innova Market Insights reported that the COVID-19 pandemic has permanently boosted consumer interest in immune health.
Combatting gastrointestinal conditions
The use of S. boulardii for managing diarrhea in adults and children has been widely prescribed by doctors and gastroenterologists for decades. Its efficacy for combating an array of gastrointestinal conditions is well documented in medical literature.
A study published in the Chinese Journal of Pediatrics concludes that certain probiotics can reduce the severity and duration of diarrhea. Among them, Lactobacillus rhamnosus GG and S. boulardii are the two most effective probiotics for anti-diarrhea treatment.
Unlike Lactobacillus probiotics, Angel’s S. boulardii Bld-3 is developed using the low-temperature fluidized bed process.
Its protection technology allows it to quickly form a dense yeast shell that encloses active yeast probiotics entrapped inside.
This process strengthens the yeast’s resistance to gastric acid and bile salts, enabling it to be applied in a wide variety of end probiotic products.
Broad range of applications
Angel’s S. boulardii Bld-3 is a suitable ingredient for wide-ranging probiotic dietary supplements. Thanks to the larger size of yeast probiotics, which is ten times as big as that of Lactobacillus probiotics, they are more likely to form a space-occupying effect in the intestinal tract and are resistant to antibiotics.
Angel Yeast also produces Saccharomyces cerevisiae probiotic and other extensive ranges of functional yeast ingredients, with several new products in the pipeline, including Kluyveromyces marxianus.
At present, probiotic products produced by Angel Yeast have been sold to Europe and North America.
Healthy gut moves
Gut health and its link between immunity continues to shake up the nutrition sector. Research by FrieslandCampina has also revealed that the gut-brain axis can also play an essential role in bolstering mental wellness.
Among other relevant research, Chr. Hansen recently spotlighted a study finding that bacterial gut imbalances play a role in the physiological changes linked with IBS and probiotics.
In other scientific advancements, colostrum-based functional foods were highlighted by PanTheryx as beneficial for gut health and immunity.
Edited by Elizabeth Green
To contact our editorial team please email us at editorial@cnsmedia.com
Subscribe now to receive the latest news directly into your inbox.